284 related articles for article (PubMed ID: 16936952)
21. Evaluating the effects of Botulinum Toxin A on tear metrics in patients with hemifacial spasm.
Mali YP; Schultze RL; Wladis EJ
Orbit; 2017 Oct; 36(5):307-310. PubMed ID: 28627956
[TBL] [Abstract][Full Text] [Related]
22. Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm.
Sacramento DRC; Lima A; Maia DP; Cunningham M; Maciel RH; Camargos ST; Cardoso F
Mov Disord; 2019 Sep; 34(9):1401-1403. PubMed ID: 31251420
[No Abstract] [Full Text] [Related]
23. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
Karp BI; Alter K
Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia.
Bladen JC; Feldman I; Favor M; Dizon M; Litwin A; Malhotra R
Eye (Lond); 2019 Mar; 33(3):349-352. PubMed ID: 30202071
[TBL] [Abstract][Full Text] [Related]
25. Use of botulinum toxin in neuro-ophthalmology.
O'Day J
Curr Opin Ophthalmol; 2001 Dec; 12(6):419-22. PubMed ID: 11734681
[TBL] [Abstract][Full Text] [Related]
26. Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions.
Ozer IS; Kuzu Kumcu M; Tezcan Aydemir S; Akbostanci MC
Clin Neurol Neurosurg; 2021 Oct; 209():106889. PubMed ID: 34461363
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
[TBL] [Abstract][Full Text] [Related]
28. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
Ho RW; Fang PC; Chao TL; Chien CC; Kuo MT
Sci Rep; 2018 May; 8(1):8367. PubMed ID: 29849166
[TBL] [Abstract][Full Text] [Related]
29. Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.
Isshiki Y; Ishikawa H; Mimura O
Jpn J Ophthalmol; 2016 Nov; 60(6):486-491. PubMed ID: 27503401
[TBL] [Abstract][Full Text] [Related]
30. The effect of botulinum toxin a treatment on tear function parameters and on the ocular surface.
Horwath-Winter J; Berglöff J; Flögel I; Haller-Schober EM; Müllner K; Schmut O
Adv Exp Med Biol; 2002; 506(Pt B):1241-6. PubMed ID: 12614060
[No Abstract] [Full Text] [Related]
31. [Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A].
Vogt T; Lüssi F; Paul A; Urban P
Nervenarzt; 2008 Aug; 79(8):912-7. PubMed ID: 18551268
[TBL] [Abstract][Full Text] [Related]
32. Effect of eyelid botulinum toxin injection on lacrimal drainage.
Sahlin S; Chen E; Kaugesaar T; Almqvist H; Kjellberg K; Lennerstrand G
Am J Ophthalmol; 2000 Apr; 129(4):481-6. PubMed ID: 10764857
[TBL] [Abstract][Full Text] [Related]
33. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
[TBL] [Abstract][Full Text] [Related]
34. Riolan's muscle: action and indications for botulinum toxin injection.
Mackie IA
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
[TBL] [Abstract][Full Text] [Related]
35. Influence of involuntary eyelid spasms on corneal topographic and eyelid morphometric changes in patients with hemifacial spasm.
Osaki T; Osaki MH; Osaki TH; Hirai FE; Nallasamy N; Campos M
Br J Ophthalmol; 2016 Jul; 100(7):963-970. PubMed ID: 26541432
[TBL] [Abstract][Full Text] [Related]
36. Lid wiper epitheliopathy in patients with blepharospasm and/or hemifacial spasm.
Romero-Caballero MD; Salmerón Ato MP; Palazón-Cabanes A; Caravaca-Alegría A
Arch Soc Esp Oftalmol (Engl Ed); 2022 Jul; 97(7):376-380. PubMed ID: 35292220
[TBL] [Abstract][Full Text] [Related]
37. What is new in the era of focal dystonia treatment? Botulinum injections and more.
Cetinkaya A; Brannan PA
Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
[TBL] [Abstract][Full Text] [Related]
38. [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].
Roggenkämper P
Ophthalmologe; 2007 Sep; 104(9):763-6. PubMed ID: 17726608
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Thussu A; Barman CR; Prabhakar S
Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
[TBL] [Abstract][Full Text] [Related]
40. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
Bastola P; Chaudhary M; Agrawal JP; Shah DN
Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]